Sep 30, 2019

Adaptimmune Q3 2019 Earnings Report

Total Revenue
$237K
Previous year: $40.8M
-99.4%
EPS
-$0.06
Previous year: $0.01
-700.0%
Gross Profit
-$29.4M
Previous year: $17.3M
-269.7%
Cash and Equivalents
$39.4M
Previous year: $153M
-74.3%
Free Cash Flow
-$29.8M
Previous year: $9.26M
-422.3%
Total Assets
$208M
Previous year: $310M
-32.7%

Adaptimmune

Adaptimmune